ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,565,000 | +78.2% | 20,400 | 0.0% | 0.01% | +66.7% |
| Q3 2020 | $878,000 | -83.4% | 20,400 | -83.3% | 0.00% | -70.0% |
| Q2 2020 | $5,278,000 | +50.9% | 122,200 | +0.5% | 0.01% | +11.1% |
| Q1 2020 | $3,498,000 | -65.2% | 121,600 | -23.2% | 0.01% | -55.0% |
| Q4 2019 | $10,048,000 | +1146.7% | 158,400 | +453.8% | 0.02% | +900.0% |
| Q3 2019 | $806,000 | -43.5% | 28,600 | -63.2% | 0.00% | -66.7% |
| Q1 2019 | $1,426,000 | +109.4% | 77,700 | +41.8% | 0.01% | +100.0% |
| Q4 2018 | $681,000 | +0.6% | 54,800 | +55.2% | 0.00% | +50.0% |
| Q3 2018 | $677,000 | +64.3% | 35,300 | +16.5% | 0.00% | 0.0% |
| Q2 2018 | $412,000 | +172.8% | 30,300 | +44.3% | 0.00% | +100.0% |
| Q1 2018 | $151,000 | +96.1% | 21,000 | 0.0% | 0.00% | – |
| Q4 2017 | $77,000 | – | 21,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |